“…Although we cannot clearly explain why the mortality risk of patients with PSRFs increased during the COVID era, one of the possible reasons could be that the standard of care for HF treatment for hospitalized patients was not maintained enough in the beginning phase of the pandemic. Additionally, the conversion of cardiology wards and heart failure units to COVID-19 wards and the reallocation of healthcare professionals to care for COVID-19 patients affected the care of HF patients 12 , 28 . However, Shoaib et al showed a significant rise in mortality from HF within 30 days of discharge during the COVID-19 pandemic despite the same practice of guideline-recommended medical therapy and interventions.…”